The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Evolent Health Inc's Score
Industry at a Glance
Industry Ranking
60 / 208
Overall Ranking
131 / 4589
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
15
analysts
Buy
Current Rating
11.036
Target Price
+158.45%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Evolent Health Inc Highlights
StrengthsRisks
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 88.96% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.55B.
Overvalued
The company’s latest PE is -2.74, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 129.03M shares, decreasing 16.42% quarter-over-quarter.
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
Ticker SymbolEVH
CompanyEvolent Health Inc
CEOMr. Seth Blackley
Websitehttps://www.evolent.com/
FAQs
What is the current price of Evolent Health Inc (EVH)?
The current price of Evolent Health Inc (EVH) is 4.310.
What is the symbol of Evolent Health Inc?
The ticker symbol of Evolent Health Inc is EVH.
What is the 52-week high of Evolent Health Inc?
The 52-week high of Evolent Health Inc is 13.615.
What is the 52-week low of Evolent Health Inc?
The 52-week low of Evolent Health Inc is 3.495.
What is the market capitalization of Evolent Health Inc?
The market capitalization of Evolent Health Inc is 480.96M.
What is the net income of Evolent Health Inc?
The net income of Evolent Health Inc is -93.45M.
Is Evolent Health Inc (EVH) currently rated as Buy, Hold, or Sell?
According to analysts, Evolent Health Inc (EVH) has an overall rating of Buy, with a price target of 11.036.
What is the Earnings Per Share (EPS TTM) of Evolent Health Inc (EVH)?
The Earnings Per Share (EPS TTM) of Evolent Health Inc (EVH) is -1.572.